Results 161 to 170 of about 22,853 (279)

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab‐soravtansine therapy

open access: yesThe Journal of Pathology: Clinical Research, Volume 12, Issue 3, May 2026.
Abstract Mirvetuximab‐soravtansine (MIRV‐S) is an antibody‐drug conjugate targeting folate receptor alpha (FOLR1). MIRV‐S is approved for the treatment of FOLR1‐positive, platinum‐resistant ovarian carcinoma. Patient eligibility is determined by immunohistochemistry (IHC) using a companion diagnostic (CDx) assay (FOLR1‐2.1, Ventana).
Annika Nasdala   +10 more
wiley   +1 more source

Efficacy of laparoscopic pelvic denervation in central-type chronic pelvic pain: A multicenter study [PDF]

open access: yes, 1996
Busacca, M.   +7 more
core   +1 more source

CNC–PNIPAM Drug Delivery System Improves Endometrial Receptivity via Natural Killer Cell Immune Tolerance in Endometriosis

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 5, May 2026.
An injectable CNC–PNIPAM hydrogel is developed for intrauterine co‐delivery of levonorgestrel and botropase. This platform reprograms uterine natural killer cells toward an immune–tolerant phenotype and enhances endometrial receptivity marker expression. The results demonstrate a promising strategy to counteract endometriosis–associated infertility and
Zhou Liang   +9 more
wiley   +1 more source

The impact of laparoscopic deep endometriosis surgery on sexual functioning and distress. [PDF]

open access: yesFacts Views Vis Obgyn
de Koning R   +7 more
europepmc   +1 more source

Systemic immune dysregulation in patients experiencing urogynaecological mesh failure

open access: yesBJUI Compass, Volume 7, Issue 5, May 2026.
Abstract Objectives This study aimed to investigate the systemic immune landscape in patients experiencing urogynaecological mesh failure. The use of urogynaecological mesh was paused in the UK following an independent safety review that found ~1 in 15 women required removal due to complications. However, the mechanisms underpinning mesh failure remain
Shannon Jamieson   +9 more
wiley   +1 more source

Fluorescence-guided nerve-sparing surgery for deep endometriosis using indocyanine green. [PDF]

open access: yesFacts Views Vis Obgyn
Kanno K   +10 more
europepmc   +1 more source

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1179-1194, May 2026.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott   +7 more
wiley   +1 more source

Urogynecological Outcomes After Minimally Invasive Surgery for Deep Endometriosis: A Systematic Review. [PDF]

open access: yesInt J Womens Health
Mascellino G   +10 more
europepmc   +1 more source

Deep endometriosis of ileocecum complicated by acute intestinal obstruction: a case report. [PDF]

open access: yesJ Int Med Res, 2023
Slama L   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy